全文获取类型
收费全文 | 6569篇 |
免费 | 474篇 |
国内免费 | 154篇 |
专业分类
耳鼻咽喉 | 92篇 |
儿科学 | 94篇 |
妇产科学 | 106篇 |
基础医学 | 336篇 |
口腔科学 | 66篇 |
临床医学 | 330篇 |
内科学 | 569篇 |
皮肤病学 | 61篇 |
神经病学 | 116篇 |
特种医学 | 503篇 |
外国民族医学 | 3篇 |
外科学 | 1272篇 |
综合类 | 454篇 |
预防医学 | 63篇 |
眼科学 | 35篇 |
药学 | 188篇 |
1篇 | |
中国医学 | 40篇 |
肿瘤学 | 2868篇 |
出版年
2024年 | 11篇 |
2023年 | 105篇 |
2022年 | 190篇 |
2021年 | 269篇 |
2020年 | 237篇 |
2019年 | 236篇 |
2018年 | 253篇 |
2017年 | 197篇 |
2016年 | 276篇 |
2015年 | 263篇 |
2014年 | 406篇 |
2013年 | 465篇 |
2012年 | 338篇 |
2011年 | 312篇 |
2010年 | 234篇 |
2009年 | 331篇 |
2008年 | 353篇 |
2007年 | 357篇 |
2006年 | 306篇 |
2005年 | 265篇 |
2004年 | 219篇 |
2003年 | 170篇 |
2002年 | 153篇 |
2001年 | 153篇 |
2000年 | 112篇 |
1999年 | 114篇 |
1998年 | 120篇 |
1997年 | 86篇 |
1996年 | 58篇 |
1995年 | 68篇 |
1994年 | 65篇 |
1993年 | 47篇 |
1992年 | 48篇 |
1991年 | 31篇 |
1990年 | 25篇 |
1989年 | 40篇 |
1988年 | 37篇 |
1987年 | 18篇 |
1986年 | 34篇 |
1985年 | 30篇 |
1984年 | 28篇 |
1983年 | 16篇 |
1982年 | 24篇 |
1981年 | 26篇 |
1980年 | 25篇 |
1979年 | 19篇 |
1978年 | 8篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1972年 | 2篇 |
排序方式: 共有7197条查询结果,搜索用时 31 毫秒
11.
Michelle L. DeOliveira Timothy M. Pawlik Ana L. Gleisner Lia Assumpcaom Gaspar J. Lopes-Filho Michael A. Choti 《Journal of gastrointestinal surgery》2007,11(8):970-976
Survival after resection of colorectal liver metastases has traditionally been associated with clinicopathologic factors.
We sought to investigate whether echogenicity of colorectal liver metastasis as assessed by intraoperative ultrasound (IOUS)
was a prognostic factor after hepatic resection. Prospective data on tumor IOUS appearance were collected in 84 patients who
underwent hepatic resection for colorectal liver metastasis. Images were digitally recorded, blindly reviewed, and scored
for echogenicity (hypo-, iso-, or hyperechoic). The median tumor number was 1 and the median tumor size was 5.0 cm. At the
time of surgery, the IOUS appearance of the colorectal liver metastases were hypoechoic in 35 (41.7%) patients, isoechoic
in 37 (44.0%) patients, and hyperechoic in 12 (14.3%) patients. Traditional clinicopathologic prognostic factors were similarly
distributed among the three echogenicity groups (all p > 0.05). Patients with a hypoechoic lesion had a significantly shorter median survival (30.2 months) compared with patients
who had either an isoechoic (53.2 months) or hyperechoic (42.3 months) lesion (p = 0.005). The 5-year survival after hepatic resection of colorectal liver metastasis was also associated with the echogenic
appearance of the lesion (hypoechoic 14.4 vs isoechoic 37.4 vs hyperechoic 46.2%) (p < 0.05). Intraoperative ultrasound echogenicity should be considered a prognostic factor after hepatic resection of metastatic
colorectal cancer.
This study was presented at the 47th annual meeting of The Society for Surgery of the Alimentary Tract, Los Angeles, CA, USA,
22 May 2006. 相似文献
12.
Takayuki Murakami Atsushi Komiya Kunihisa Mikata Shigeki Kaneko Ichiro Ikeda 《International journal of urology》2007,14(3):240-241
Abstract: A 66-year-old man was referred to our hospital with chest discomfort and shortness of breath. Seven months previously he had undergone a laparoscopic left nephroureterectomy for a left renal pelvic tumor and was given two cycles of adjuvant chemotherapy (methotrexate, epirubicin and cisplatin). Echocardiogram showed an 8-mm sized mass extending from the right atrium into the right ventricle. On computed tomography, multiple lung tumors, as well as the right atrial and ventricular mass, were seen. The patient died of acute heart failure caused by right ventricular outflow obstruction. On autopsy, a right atrial and ventricular metastasis of the initial transitional cell carcinoma was found. The patient's cause of death was acute heart failure as a result of cardiac metastasis of his initial renal pelvic carcinoma. 相似文献
13.
What factors influence survival in patients with unresected synchronous liver metastases after resection of colorectal cancer? 总被引:3,自引:0,他引:3
N. Chafai C. L. H. Chan E. L. Bokey O. F. Dent G. Sinclair P. H. Chapuis 《Colorectal disease》2005,7(2):176-181
OBJECTIVE: The aim of this study was to determine whether the survival of patients with untreated synchronous liver metastases after resection of a colorectal cancer was associated with any features of the primary tumour. METHODS: Information for 398 consecutive patients with unresected liver metastases in the period 1971-2001 was examined by multivariate survival analysis. RESULTS: Of 19 clinical and pathological variables considered, survival was independently associated only with residual tumour in a line of resection (hazard ratio (HR) 1.95), venous invasion (HR 1.87), right colonic tumour (HR 1.68), lymph node metastasis (HR 1.54), and extra-hepatic metastasis (HR 1.16); 8.3% of patients had none of these adverse features. Their 2-year overall survival rate was 39.2%, compared with only 16.5% (P < 0.001) in those with one or more adverse features. CONCLUSIONS: These findings may assist in selecting patients most likely to benefit from treatment of hepatic metastases and in counselling patients and their relatives. 相似文献
14.
Dr. J. Tajti MD PhD ; Dr. K. Sas MD ; Dr. D. Szok MD ; Dr. E. Vörös MD ; Dr. L. Vécsei MD DSc 《Headache》1996,36(4):259-260
We report on a patient with clusterlike headache and multiple brain metastases of lung cancer. Initially, cluster headache was suggested clinically by characteristic symptoms without any focal central nervous system signs. However, magnetic resonance imaging demonstrated multiple brain metastases. It is possible that tumor necrosis factor may have played a role in initiating the clusterlike headache. 相似文献
15.
16.
Skip mediastinal nodal metastases in non-small cell lung cancer 总被引:1,自引:0,他引:1
Fumihiro Tanaka Kazumasa Takenaka Hiroki Oyanagi Takuji Fujinaga Yosuke Otake Kazuhiro Yanagihara Harumi Ito Hiromi Wada 《European journal of cardio-thoracic surgery》2004,25(6):744-1120
Objective: To reveal the incidence and clinical significance of mediastinal nodal metastases without N1-station nodal metastases (‘skip-N2 metastases’) in non-small cell lung cancer (NSCLC). Methods: A total of 450 NSCLC patients who underwent tumor resection with a systemic mediastinal nodal dissection were retrospectively reviewed. p53 status and proliferative activity represented as proliferative index (PI) were also examined immunohistochemically. Results: Skip-N2 metastases were documented in 49 (13%) patients of all 450 patients; among 334 patients without N1-nodal involvement, 18% patients had skip-N2 metastases. The postoperative survival of skip-N2 patients was almost same as that for patients with metastases to both N1 and N2 nodes. Skip-N2 metastases were significantly more frequent in male patients and squamous cell carcinoma patients. In addition, the mean PI for tumor with skip-N2 metastases was significantly higher than that for any other pathologic nodal (pN)-status diseases. Combined with histologic type and PI, the incidences of skip-N2 metastases for adenocarcinoma showing lower PI were only 5% (7/137) of all patients and 7% (7/94) of patients without N1-nodal involvement. Conclusions: N1 nodal status is not a useful predictor of N2 nodal status in NSCLC, because skip-N2 metastases were documented in 18% patients showing no N1-nodal involvement. However, N1 node-guided dissection might be performed in patients with adenocarcinoma showing lower PI, because the incidence of skip-N2 metastases was extremely low. 相似文献
17.
目的:探讨全肺放疗治疗肺转移癌的价值.方法:1999年3月~2003年5月我院肿瘤科收治24例双肺多发肺转移癌患者,均给予全肺放疗.现对这些患者的临床资料进行总结分析.结果:本组放疗结束时转移瘤CR率为37.5%(9/24),PR率为50.0%(12/24),有效率(PR+CR)达87.5%.原发肿瘤为鼻咽癌、乳腺癌、肝癌、结直肠癌的中位生存期分别为13.5、22.0、10.5月、8.5月.1~2级放射性肺炎发生率为25.0%(6/24);3级为16.7%(2/24);4~5级为0.结论:恶性肿瘤肺多发转移可以采用全肺放疗+局部小野补量治疗,尤其适用于原发肿瘤对放疗中高度敏感、化疗无效的患者,可获得较好疗效.毒副作用可耐受. 相似文献
18.
放射治疗71例骨转移癌止痛效果分析 总被引:2,自引:0,他引:2
目的观察低于常规剂量的2种分割方式治疗骨转移性疼痛的疗效。方法71例恶性肿瘤晚期骨转移患者,总计93处骨转移灶,根据疼痛程度及行动受限程度,采取2种均低于常规剂量的分割方式进行放射治疗,分别为Dm30Gy/10f/2W,Dm30Gy/6f/2W。观察疼痛缓解情况。结果2种分割方式止痛有效率分别为88%、95%。两组间无显著差异性(P>0.05)。与国内多数文献报告的结果接近。结论低于常规剂量的分割方式对转移性骨痛疗效与常规剂量的分割方式的疗效相当,且简便易行。 相似文献
19.
EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force 总被引:2,自引:0,他引:2
R. Soffietti P. Cornu J. Y. Delattre R. Grant F. Graus W. Grisold J. Heimans J. Hildebrand P. Hoskin M. Kalljo P. Krauseneck C. Marosi T. Siegal C. Vecht 《European journal of neurology》2006,13(7):674-681
The objectives have been to establish evidence-based guidelines and identify controversies regarding the management of patients with brain metastases. The collection of scientific data was obtained by consulting the Cochrane Library, bibliographic databases, overview papers and previous guidelines from scientific societies and organizations. A tissue diagnosis is necessary when the primary tumor is unknown or the aspect on computed tomography/magnetic resonance imaging is atypical. Dexamethasone is the corticosteroid of choice for cerebral edema. Anticonvulsants should not be prescribed prophylactically. Surgery should be considered in patients with up to three brain metastases, being effective in prolonging survival when the systemic disease is absent/controlled and the performance status is high. Stereotactic radiosurgery should be considered in patients with metastases of 3–3.5 cm of maximum diameter. Whole-brain radiotherapy (WBRT) after surgery or radiosurgery is debated: in case of absent/controlled systemic cancer and Karnofsky Performance score of 70 or more, one can either withhold initial WBRT or deliver early WBRT with conventional fractionation to avoid late neurotoxicity. WBRT alone is the treatment of choice for patients with single or multiple brain metastases not amenable to surgery or radiosurgery. Chemotherapy may be the initial treatment for patients with brain metastases from chemosensitive tumors. 相似文献
20.
Richard Simpson Catherine Kennedy Hugh Carmalt Brian McCaughan David Gillett 《ANZ journal of surgery》1997,67(10):717-719
Background : A patient with a solitary pulmonary metastasis who had breast cancer in the past may benefit from pulmonary resection. Methods : Between 1984 and 1996, 17 patients underwent metastatectomy for metastatic breast cancer. There were 15 females and two males whose average age was 59 (range: 40–74 years). The median tumour-free interval after the primary breast-cancer operation was 5.1 years (range: 8 months-18.2 years). Sixteen patients had complete resections, which included six lobectomies and 10 lesser resections. Results : The postoperative mortality was nil and the morbidity rate was 6%. Follow-up was complete in all patients. Recurrent disease developed in four patients and two patients died of their disease. The 5-year survival was 62%. Conclusion : An aggressive surgical approach is warranted in patients with isolated resectable pulmonary metastases from breast cancer. 相似文献